is there a lawsuit against semaglutide Filed Ozempic & Wegovy Makers Judicial Panel Authorizes New GLP-1

This effect is a result of peripheral and central GLP-1 receptor activation, and is afforded by the ability of GLP-1 RAs to cross the blood brain barrier (BBB) [130]

[1] [2] GLP-1 agonists work by mimicking a naturally occurring hormone called glucagon-like peptide-1, which regulates appetite and food intake

The UK product information includes a warning (though not a formal contraindication) for patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, advising vigilance for symptoms such as neck lumps or hoarseness

The specific medication matters enormously

Previous shortages of GLP-1 RAs impacted patient care, leading to concerns that these medications should be reserved for patients with diabetes rather than weight loss in otherwise healthy individuals

Nonetheless, investigators from the Canadian Network for Observational Drug Effect Studies (CNODES) reported contradictory results